Forum Πρωτοβάθμιας Φροντίδας Υγείας
ΠΦΥ -Εκπαίδευση => Αποσπάσματα από τον έντυπο & ηλεκτρονικό τύπο => Μήνυμα ξεκίνησε από: Argirios Argiriou στις 11 Ιουνίου 2014, 19:58:45
-
Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases.
BMJ 2014; 348 doi: http://dx.doi.org/10.1136/bmj.g3244 (Published 29 May 2014)
Cite this as: BMJ 2014;348:g3244
http://www.bmj.com/content/348/bmj.g3244
και το σχόλιο του Journal Watch:
Higher doses of statins are associated with greater risk for incident diabetes than lower doses, according to a BMJ study.
Using healthcare databases from Canada, the UK, and the US, researchers identified 137,000 patients who were prescribed statins after hospitalization for a major cardiovascular event. At 2 years, patients prescribed a higher-dose statin (rosuvastatin, 10 mg and up; atorvastatin, 20 mg and up; simvastatin, 40 mg and up) had a 15% higher rate of new diabetes diagnoses than lower-dose statin users. Incidence rates were highest in the first 4 months.
http://www.jwatch.org/fw108892/2014/06/02/higher-dose-statins-linked-moderate-increase-diabetes?query=most-popular-read#sthash.0dAN5KAB.dpuf